Search by keyword

24 result(s) found, displaying 1 to 20 | Clear filters

2020
Publication, report or update

Version 1.2 updated in August 2020

2020
Publication, report or update
2020
Publication, report or update

This publication summarises medicines that were in use or being investigated to treat COVID-19 as at 7 October 2020. This publication remains available for reference but the information has not been updated since October 2020. The Commission acknowledges the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists for their contribution to this work.

For current resources, the National COVID-19 Clinical Evidence Taskforce has been established to provide evidence-based recommendations to guide care for people with COVID-19. The Taskforce undertakes detailed analyses of medicines for use in the treatment of COVID-19 which are updated as new research becomes available. The reviews are accompanied by therapy recommendations established through a consultation process.

Last updated 7 October 2020

2020
Publication, report or update

The Commission has developed Australia's response to the World Health Organization (WHO) Global Patient Safety Challenge: Medication without harm.

2020
Publication, report or update

This report provides analyses of data on confirmed critical antimicrobial resistances (CARs) submitted to the National Alert System for Critical Antimicrobial Resistances (CARAlert) for 2019, and trend data for 2017 to 2019.

2020
Publication, report or update
2020
Publication, report or update
2020
Publication, report or update
2020
Publication, report or update

This document provides instructions on how to utilise two work boards within OrgTRx – one for data reported using CLSI guidelines, and another for data reported using EUCAST – to assist APAS contributors to extract data to create antibiograms.

2020
Publication, report or update

A literature review to better understand the use of antipsychotic medicines for people aged 65 years and over.

2020
Publication, report or update

A report reviewing the implementation of the Australian Open Disclosure Framework identifying perceived implementation gaps, areas for improvement, and suggested strategies at a national, state and territory, and health service organisation level.

2020
Publication, report or update

This report provides the latest update report for data submitted to CARAlert for the reporting period: 1 May 2020 to 30 June 2020, and complements previous analyses of and updates on CARAlert data.

2020
Publication, report or update

As part of the work of the Antimicrobial Use and Resistance in Australia (AURA) Surveillance System, analyses of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia data collected by the Australian Group on Antimicrobial Resistance (AGAR) from 2013 to 2018 identified important national and state and territory trends. These trends can be used to inform local therapeutic, quality improvement and infection prevention and control initiatives.

2020
Publication, report or update

The Australian Commission on Safety and Quality in Health Care is seeking your feedback to ensure the NSQPH Standards meets the needs and expectations of the sector and the community. The consultation has now closed. The Commission is reviewing the information received, which will inform the finalisation of the NSQPH Standards for publication in 2021.

2020
Publication, report or update

This report includes analyses of detailed information about prescribing practices for surgical antimicrobial prophylaxis in 2019. The findings can be used to guide quality improvement programs and improve overall care for patients having surgery.

2020
Publication, report or update

This report presents analyses of data collected for the 2019 Aged Care National Antimicrobial Prescribing Survey (AC NAPS) and includes comparisons with 2016, 2017 and 2018 AC NAPS data.